Drug Type Small molecule drug |
Synonyms (+-)-1-(p,alpha-Diphenylbenzyl)imidazole, 1-((4-Biphenylyl)phenylmethyl)-1H-imidazole, 1-(alpha-(4-Biphenylyl)benzyl)imidazole + [22] |
Target |
Mechanism fungal CYP51A1 inhibitors(Fungal CYP51A1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date JP (08 May 2009), |
Regulation- |
Molecular FormulaC22H18N2 |
InChIKeyOCAPBUJLXMYKEJ-UHFFFAOYSA-N |
CAS Registry60628-96-8 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D01775 | Bifonazole |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Candidiasis | JP | 08 May 2009 | |
Tinea | JP | 08 May 2009 | |
Tinea Pedis | JP | 08 May 2009 | |
Tinea Versicolor | JP | 08 May 2009 | |
Mycoses | - | - | - |